---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-104177"
form_type: "8-K"
ticker: "LABT"
cik: "0002079272"
company_name: "Lakewood-Amedex Biotherapeutics Inc."
filed_at: "2026-09-28T21:49:48+00:00"
generated_at: "2026-10-12T13:39:29.006211+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Lakewood-Amedex holders approve raising authorized shares to 100M and reverse split up to 1:20

## Summary
- Stockholders approved increasing authorized common stock from 12,500,000 to 100,000,000 shares (927,022 for, 341,843 against, 711 abstain).
- Board authorized, at its discretion, to effect one or more reverse stock splits at a cumulative ratio not exceeding 1-for-20 (922,614 for, 333,546 against).
- 2020 Equity Incentive Plan amended to raise shares issuable thereunder to 400,000 (951,373 for, 317,012 against, 1,191 abstain).
- All four nominees elected as directors: Kelvin Cooper, Doug Manion, Leonard J. DeRoma and Joseph Tucker, each with roughly 939,000-976,000 votes for.
- CBIZ CPAs P.C. ratified as independent auditor (1,041,961 for, 33,322 against, 238,766 abstain); 2,369,688 shares were outstanding as of the July 30, 2026 record date.

## SEC filing metadata
- accession: 0001213900-26-104177
- form_type: 8-K
- ticker: LABT
- cik: 0002079272
- company_name: Lakewood-Amedex Biotherapeutics Inc.
- filed_at: 2026-09-28T21:49:48+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2079272/000121390026104177/0001213900-26-104177-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2079272/000121390026104177/ea0306660-8k_lakewood.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-104177
- JSON: https://secwatch.observer/filing/0001213900-26-104177.json
- Plain text: https://secwatch.observer/filing/0001213900-26-104177.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.